Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,175.97 -23.72 -0.74%
FTSE 100 6,674.74 -7.02 -0.11%
DAX 9,544.19 -55.90 -0.58%
Ticker Volume Price Price Delta
NIKKEI 14,546.27 157.50 1.09%
TOPIX 1,173.81 11.31 0.97%
HANG SENG 22,509.64 -221.04 -0.97%

MannKind Corporation to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum



  MannKind Corporation to Present at Canaccord Genuity Medical Technologies &
  Diagnostics Forum

Canaccord Genuity Medical Technology & Diagnostics Forum 2013

Business Wire

VALENCIA, Calif. -- November 7, 2013

MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and
commercializing treatments for diabetes, announced today that it will present
at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday,
November 14, 2013 at 11:30 AM (ET) at the Westin Grand Central in New York
City.

Interested parties can access a link to the live webcast of the presentations
from the News & Events section of the Company's website
at http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and
commercialization of therapeutic products for patients with diseases such as
diabetes. Its lead product candidate, AFREZZA®, has completed Phase 3 clinical
trials. MannKind maintains a website at www.mannkindcorp.com to which MannKind
regularly posts copies of its press releases as well as additional information
about MannKind. Interested persons can subscribe on the MannKind website to
e-mail alerts that are sent automatically when MannKind issues press releases,
files its reports with the Securities and Exchange Commission or posts certain
other information to the website.

Contact:

MannKind Corporation
Matthew Pfeffer
Chief Financial Officer
(661) 775-5300
mpfeffer@mannkindcorp.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement